Our longer term winner is clearly open digital innovation

March 5, 2015Posted inAchieving innovation engagement, Advancing innovation, amplifying the innovation signal, Improve Collaboration & Communication, innovation execution delivery, Molecules, Sustainability, Tackling innovation

Open digital innovationIn my last post I was discussing the effect digital would be having on our innovation activities, be these presently opened or closed.

The impact of digital innovation changes the innovation paradigm significantly.

Organizations can stay digitally closed in their innovation activities, moving beyond simply developing innovation solutions themselves into a connected (closed) network, where the platform becomes the enabling force and those that join share common ground or purpose but are pursuing separate value propositions that required this ‘extended’ collaboration to achieve this position.

These ‘closed systems’ can give a level of competitive advantage but these are increasingly transitory depending on the complexity and uniqueness of the eventual value proposition. Collaborative platforms are clearly the way to go to open-up innovation that allows more radical and complex solutions to be provided.

We will see a new wave of open digital innovation

Are you going all digital on me?

March 1, 2015Posted inAchieving innovation engagement, Foster Performance, Fresh thinking, gaining innovation momentum, innovation execution delivery, Interests, Molecules, Shifting dynamics in innovation, Tackling innovation1 Comment

Going all digital on meWell then, are you going all digital on me from your innovation activities?

Take care, it does change our view of the world, as we look inside-out or even, outside-in

So there we all were, getting really very comfortable in our open innovation activities, learning to collaborate and co-create outside our organizations.

Even our management has finally got “open innovation”.

We are encouraged and allowed to collaborate outside our four walls of the organization as the penny has finally dropped that “not all knowledge resides within the company”.

We had worked through some of the cultural stuff, shifted around the team who like to collaborate, pushing others less collaborative to the back; the conflict points, we had established the process, practice and tools.

We even have our legal teams on board helping sort out all the conflicting positions that open innovation can mean when it comes to dividing up the IP spoils and even had our leadership tuned in, singing our praises and even (heavens forbid) getting engaged in the process.

When the world shifts, we all need to as well, or we get left behind.

Open Innovation, Technology Platforms and a New Business Model- All-in-One Biggie!

January 5, 2012Posted inAchieving innovation engagement, Advancing innovation, Building Innovation Capability, gaining innovation momentum, Improve Collaboration & Communication, Integrated Innovation Thinking, Leading innovation, Shifting dynamics in innovation, Tackling innovation

Recently I was reminded about one of the most ambitious open innovation projects around- the Innovation Medicines Initiative- set up here in Europe. I think you will find this interesting to pick up upon.

Without doubt, this is one of the most highly ambitious and bold initiatives I’ve come across.

I think anyone seriously interested in the combination of open innovation, the use of a collaborative technology platform built around a novel new business model within such a highly competitive industry of Pharmaceuticals should watch this initiative with growing interest.

It can point to significant changes in the impact and contribution of innovation management.

From its initial concept inception in 2004 and 2005, with the IMI established in 2007 as a Joint Undertaking, it has operated as an autonomous body for approximately a little over two years as I understand it.

Here I provide a fairly concise outline of its evolution and what challenges it is currently facing. It still is too long but it provides the essentials (I hope) on an amazing and bold initiative here in Europe and is worth reading until the end-really!

Background to the Innovation Medicines Initiative (IMI)